Conditional Reprogramming: An Interview with Dr. Richard Schlegel on Growing Cancer Cells

Dr. Richard Schlegel describes an innovative cell culture technique he helped to develop. Called conditional reprogramming, the technique can be...

Study Shows Platelets Can Deliver Immunotherapy, Reduce Tumor Regrowth

In experiments in mice, researchers show platelets linked to an immunotherapy drug can help eliminate residual cancer cells that remain...

Targeted Cancer Drug May Also Help Protect Fertility, Study Suggests

Findings from a new study in mice suggest that a class of targeted cancer drugs may have another use in...

Blinatumomab Extends Survival for Patients with Advanced ALL

Patients with previously treated acute lymphoblastic leukemia who received blinatumomab, which encourages the immune system to kill cancer cells, lived...

Advancing the Potential and Promise of Total-Body PET Imaging

A total-body PET scanner under development is an ideal example of how NCI and NIH are supporting the development of...

Studies Identify Potential Treatment Strategies for Pediatric DIPG Brain Tumors

Two studies have identified proteins that drive growth of diffuse intrinsic pontine glioma (DIPG) tumor cells. Blocking these targets with...

FDA Approves Pembrolizumab for Hodgkin Lymphoma

The FDA approved pembrolizumab for the treatment of some adult and pediatric patients with classical Hodgkin lymphoma. Source link

PARP Inhibitors May Be Effective in Brain, Other Cancers with IDH Mutations

Studies presented at the 2017 AACR annual meeting suggest that therapies which take advantage of the mutations in the IDH...

Patients Who Choose No Intervention for Small Thyroid Cancers Report Lack of Support

Patients who choose not to pursue immediate biopsy or treatment for small, asymptomatic thyroid cancers, or suspected cancers, can experience...